Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results

Jagsonpal Pharmaceuticals Financial Results

Jagsonpal Pharmaceuticals reported FY26 total income of ₹299.22 Crore and Net Profit of ₹43.08 Crore. The Board recommended a dividend of ₹4 (200%) per equity share. Additionally, a buy-back of up to 16,00,000 equity shares at ₹250 per share was previously approved, totaling ₹40 Crore.

Source

BSE filing, NSE: JAGSNPHARM. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Jagsonpal Pharmaceuticals Ltd: key numbers

Share price
₹230.96
Market cap
₹1,523 Cr
Revenue (annual)
₹287.2 Cr
Net profit (annual)
₹43.08 Cr
P/E (TTM)
33.5×Sector 46.1×
Promoter holding
68.81%-0.24% QoQ
FII holding
2.13%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Jagsonpal Pharmaceuticals Ltd

All →

Other financial results announcements

All →